← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #75 OF 1,000 MOST-CITED

Calibration/Inspection/Checking not done

FDA cited this observation 285 times across 265 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs285
BY FISCAL YEAR
FY202612
FY202533
FY202424
FY202323
FY202230
FY202118
FY202023
FY201947
FY201847
FY201728

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 3.7× the rate of the average FDA-cited firm (30.9% vs 8.3%), across 265 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your Professional access…

How FDA worded it — real examples

Routine calibration of automatic and electronic equipment is not performed according to a written program designed to assure proper performance.

Blessings International · Broken Arrow, Oklahoma · Drugs · 2026-05-14

Routine checking of mechanical and electronic equipment is not performed according to a written program designed to assure proper performance.

Similasan AG · Jonen · Drugs · 2026-04-27

Routine calibration of electronic equipment is not performed according to a written program designed to assure proper performance.

Global Packaging Systems, Inc · Fort Worth, Texas · Drugs · 2026-04-09

Routine inspection of mechanical equipment is not performed according to a written program designed to assure proper performance.

MD Logistics, LLC · Plainfield, Indiana · Drugs · 2026-04-03

Routine calibration of automatic and electronic equipment is not performed according to a written program designed to assure proper performance.

Eosera, Inc. · Fort Worth, Texas · Drugs · 2026-03-20

Routine calibration of mechanical equipment is not performed according to a written program designed to assure proper performance.

Tropical Seas, Inc. · Holly Hill, Florida · Drugs · 2026-02-12

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →